Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact the trial administrator to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- USC/Kenneth Norris Comprehensive Cancer Center USC/Norris, Los Angeles, California, 90033
- Cedars Sinai Medical Center SC, Los Angeles, California, 90048
- Scripps Clinic Regulatory, La Jolla, California, 92121
-
Oregon
- Oregon Health & Science University OH&SU, Portland, Oregon, 97239
-
Colorado
- University of Colorado SC, Aurora, Colorado, 80045
-
Texas
- Texas Oncology, P.A. TX Onc Baylor, Dallas, Texas, 75251
- Texas Oncology, P.A. Texas Oncology - Amarillo, Dallas, Texas, 75251
- Texas Oncology Texas Oncology - Amarillo, Dallas, Texas, 75251
- Texas Oncology TX Oncology Baylor, Dallas, Texas, 75251
-
Illinois
- University of Chicago Medical Center UC SC, Chicago, Illinois, 60546
-
Tennessee
- Vanderbilt University Medical Center Vanderbilt Med Ctr, Nashville, Tennessee, 37232
-
Indiana
- Indiana University Health Goshen Center for Cancer IU Health - SC, Indianapolis, Indiana, 46202
-
Italy
- Novartis Investigative Site, Napoli, 80132
- Novartis Investigative Site, Napoli, 80131
-
Czech Republic
- Novartis Investigative Site, Brno, 65653
-
FI
- Novartis Investigative Site, Firenze, FI, 50134
-
Germany
- Novartis Investigative Site, Magdeburg, 39120
Powered by
SC CTSI